Ms. Tasnova Tasnim Nova

Journal articles

2021

Islam MR, Nova TT, Momenuzzaman N, et al, 2021. Prevalence of CYP2C19 and ITGB3 polymorphisms among Bangladeshi patients who underwent percutaneous coronary intervention. SAGE Open Medicine, 9, p.1.

Islam S, Akand AR, Nova TT, Lehmann C, Chisti MJ, 2021. Sensitivity Patterns of Bacterial Pathogens Isolated from Blood Cultures of Under-Five Children with Pneumonia and Clinical Sepsis. Life (Basel), 11(5), p.450.

Begum MM, Rivu SF, Hasan MMA, Nova TT, et. al., 2021. Disposal Practices of Unused and Leftover Medicines in the Households of Dhaka Metropolis. Pharmacy, 9(2), p.103.

2020

Rashid, M.M.U., Ahmed, I., Islam, M.A. T Tasnova et al., 2020. Influence of TPMT polymorphisms on azathioprine-induced myelosuppression in Bangladeshi patients with systemic lupus erythematosus. Drugs & Therapy Perspectives, 36, p.202.

Nova TT et. al., 2020. CYP2C19*2, CYP2C19*17 and ITGB3 (PlA1/A2) polymorphisms and resulting therapeutic alterations of clopidogrel and aspirin: A clinical screening among CVD patients who undergone PCI. bioRxiv (Preprint), doi: https://doi.org/10.1101/2020.10.04.325258.

2019

Islam Z, Tahsin MR, Faisal, AU, Tithi TI, Nova TT et al., 2019. In vivo Assessment of Antidiabetic Potential and Mapping of Pharmacological Properties of Ethanolic Extract of Leaves of Coccinia grandis on Alloxan-induced Diabetic Rats. Asian Journal of Advanced Research and Reports, pp.1-9.

2017

Nova TT., et al , 2017. Genetic variants of SULT1A1 and XRCC1 genes and risk of lung cancer in Bangladeshi population. Tumor Biology, 39(11), p.1.

Conference proceedings

2026

Nova TT, Li Manjun, Robinson N, Thomas D, 2026. IDH1 mutation reprograms differentiation and therapeutic response to FGF receptor blockade in cholangiocarcinoma. Annals of Oncology. (Abstract accepted)

Nova TT, Robinson N, Thomas D, 2026. IDH1 mutation reprograms differentiation and therapeutic response in cholangiocarcinoma. ESMO open. (Abstract accepted)

2025

Nova TT, Robinson N, Thomas D, 2025. Induction of cell differentiation alters therapeutic sensitization in IDH1-Mutant Cholangiocarcinoma: New Strategies for a Challenging Cancer. Asia-Pacific Journal of Clinical Oncology, 21, p.25.